Kiniksa Pharmaceuticals, Ltd. (KNSA)
NASDAQ: KNSA · IEX Real-Time Price · USD
17.88
+0.27 (1.53%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Kiniksa Pharmaceuticals Revenue
Kiniksa Pharmaceuticals had revenue of $301.77M in the twelve months ending March 31, 2024, with 27.69% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $79.86M with 65.18% year-over-year growth. In the year 2023, Kiniksa Pharmaceuticals had annual revenue of $270.26M with 22.74% growth.
Revenue (ttm)
$301.77M
Revenue Growth
+27.69%
P/S Ratio
4.18
Revenue / Employee
$1,016,067
Employees
297
Market Cap
1.26B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 270.26M | 50.08M | 22.74% |
Dec 31, 2022 | 220.18M | 181.64M | 471.24% |
Dec 31, 2021 | 38.54M | - | - |
Dec 31, 2020 | 0 | - | - |
Dec 31, 2019 | 0 | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 0 | - | - |
Dec 31, 2016 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Brookdale Senior Living | 3.02B |
Omnicell | 1.15B |
Pacira BioSciences | 674.98M |
Ironwood Pharmaceuticals | 442.74M |
4D Molecular Therapeutics | 20.72M |
Tarsus Pharmaceuticals | 17.45M |
KNSA News
- 4 days ago - Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution - GlobeNewsWire
- 11 days ago - Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024 - GlobeNewsWire
- 25 days ago - Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart - GlobeNewsWire
- 2 months ago - Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution - GlobeNewsWire
- 2 months ago - Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024 - GlobeNewsWire
- 4 months ago - Kiniksa Pharmaceuticals Provides Corporate Update - GlobeNewsWire
- 4 months ago - Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 months ago - Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio Execution - GlobeNewsWire